Pantothenic acid preparations improve the condition of patients with coronary heart disease and stable angina.
[Therapeutic efficacy of pantothenic acid preparations in ischemic heart disease patients].
AI Summary
Key Findings
Abstract
The therapeutic effectiveness of the pantothenic acid drugs: calciipantothenas and pantethine, was studied in 182 patients with coronary heart disease and stable angina of effort. It is shown that both the drugs produce favourable effects on certain parameters of hemodynamics, on the metabolism of lipids, riboflavin and ascorbic acid. It is recommended that the administration of calciipantothenas in a dose of 300 mg/day, during 3 weeks, be included into the combined treatment of coronary patients with no manifest disorders of lipid metabolism. Patients with manifest hyperlipidemia should be administered pantethine in a dose of 500 mg/day.
External References
- PubMed ID:
- 3590676
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.